Related stories Verily's reshuffling Verily spun out of Google's moonshot group in 2015 and remained part of Alphabet's collection of long-term businesses, sometimes called "other bets." ...
Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet.
When Dr. Amy Abernethy joined Verily in July, her goal was to "catapult" the company's clinical-research business into its next phase, company CEO Andy Conrad said at the time. The Google spin-off ...
Verily, Alphabet's life sciences subsidiary, has set a deadline of December 16 to sever multiple ties to Google, according to two people familiar with the matter and internal documents reviewed by ...
Alphabet’s life sciences division Verily has unveiled its latest healthcare collaboration – this time in the form of a joint diabetes venture with Sanofi. The joint venture will be under the ...
A firm from Google's parent company Alphabet has stopped ... The device was supposed to assist people living with diabetes. Verily had partnered with pharmaceutical giant Novartis to develop ...